Celltrion Pharm Inc
KOSDAQ:068760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
KR |
|
Mind CTI Ltd
NASDAQ:MNDO
|
IL |
|
Teledyne Technologies Inc
NYSE:TDY
|
US |
|
Furniweb Holdings Ltd
HKEX:8480
|
MY |
|
DFDS AS
CSE:DFDS
|
DK |
|
Kagome Co Ltd
TSE:2811
|
JP |
|
AMG Advanced Metallurgical Group NV
LSE:0LO9
|
NL |
|
S
|
Shenzhen Minglida Precision Technology Co Ltd
SZSE:301268
|
CN |
|
Molson Coors Canada Inc
TSX:TPX.A
|
CA |
|
C
|
CVRx Inc
NASDAQ:CVRX
|
US |
|
E
|
ECOS (India) Mobility & Hospitality Ltd
NSE:ECOSMOBLTY
|
IN |
|
Senko Group Holdings Co Ltd
TSE:9069
|
JP |
Bankruptcy Probability
Celltrion Pharm Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celltrion Pharm Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
2.6T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celltrion Pharm Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celltrion Pharm Inc has total debt of 168B KRW. This includes both short-term (150.8B KRW) and long-term (17.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.
